Back to search
FDAFDA · Food and drugs·Recall number D-0520-2022

Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0808-02

Published February 9, 2022 · Recall initiated: January 10, 2022

Summary

FDA records drug Class II recall D-0520-2022, published February 9, 2022 and initiated January 10, 2022. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 1,175 Bottles; Lot: Lot #: 100022970, Exp. 08/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA
Distributor
nationwide in the USA
Lot
Lot #: 100022970, Exp. 08/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0808-02 recalled?

Yes. FDA published recall D-0520-2022 on February 9, 2022. Reported hazard: Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter